![Naimish Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Naimish Patel
Hoofd Techniek/Wetenschap/O&O bij
CRISPR THERAPEUTICS AG
Vermogen: 1 M $ op 30-09-2026
Profiel
Dr. Naimish Patel, MD, is a Chief Medical Officer at CRISPR Therapeutics AG.
He is on the Board of Directors at AgomAb Therapeutics NV.
Dr. Patel was previously employed as a Global Head-Dupilumab Program by Sanofi.
He received his undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from McGill University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-05-2026 | 19.357 ( 0,02% ) | 1 M $ | 30-09-2026 |
Actieve functies van Naimish Patel
| Bedrijven | Functie | Begin |
|---|---|---|
| CRISPR THERAPEUTICS AG | Hoofd Techniek/Wetenschap/O&O | 28-05-2024 |
| AGOMAB THERAPEUTICS NV | Directeur/Bestuurslid | 11-09-2026 |
Eerdere bekende functies van Naimish Patel
| Bedrijven | Functie | Einde |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
Opleiding van Naimish Patel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
30
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
